
Pantarokk 40mg Injection
Marketer
Rokkwinn Healthcare
Salt Composition
Pantoprazole (40mg)
Overview Pantarokk 40mg Injection
Gastro-Gard 40mg Injection diminishes gastric acid production. Indicated for treating stomach and intestinal acid-related disorders including gastroesophageal reflux disease, peptic ulcers, and Zollinger-Ellison syndrome, it alleviates symptoms and facilitates healing. It's also prophylactic against stress ulcers in critically ill patients and is administered pre-anesthesia to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), this intravenous injection, administered by a healthcare professional, is reserved for patients where injectable administration is deemed clinically preferable to oral formulations. Dosage and treatment duration are determined by your physician based on individual needs and response. Consistent adherence to the prescribed regimen is crucial, even with rapid symptom resolution. Lifestyle modifications, such as consuming smaller, more frequent meals and avoiding caffeine, spicy foods, and high-fat items, can enhance treatment efficacy. Common side effects, generally mild, may include nausea, vomiting, headache, dizziness, flatulence, diarrhea, abdominal pain, and thrombophlebitis. Persistent or bothersome side effects warrant medical attention. Prolonged use (over one year) may increase the risk of bone fractures, particularly at higher doses; discuss bone health strategies, such as calcium and vitamin D supplementation, with your doctor. This medication is contraindicated in individuals with severe hepatic impairment, those on HIV medications, those with a history of PPI allergy, or pre-existing osteoporosis. Pregnant or lactating women should seek medical counsel before use. Alcohol consumption should be avoided due to its acid-stimulating properties. Refrain from operating machinery or driving if experiencing dizziness or drowsiness.
Uses of Pantarokk 40mg Injection
Management of gastroesophageal reflux disorder (GERD), peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Pantarokk 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Pantarokk 40mg Injection:
- Diarrhea
- Flatulence
- Headache
- Joint pain
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Thrombophlebitis
How to use Pantarokk 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Pantarokk 40mg Injection works:
Gastric acid secretion is diminished by the proton pump inhibitor Pantarokk 40mg Injection, thereby alleviating symptoms of heartburn and acid indigestion.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Pantarokk 40mg Injection is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Administering Pantarokk 40mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The use of Pantarokk 40mg Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Pantarokk 40mg Injection on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Pantarokk 40mg Injection poses no safety concerns for patients with kidney impairment; no dosage alteration is necessary.
LiverCAUTION
For patients exhibiting severe hepatic impairment, administration of Pantarokk 40mg Injection requires careful monitoring. Dosage modification of Pantarokk 40mg Injection may be necessary. Physician consultation is advised.
What if you forget to take Pantarokk 40mg Injection :
Should you forget a scheduled dose of Pantarokk 40mg Injection, seek your physician's advice.
Facts to Know About Pantarokk 40mg Injection
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Actions | Gastric acid suppressants |
